AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
ABBV vs CVS Fundamental Comparison
| Metric | ABBV | CVS |
|---|---|---|
| Revenue | $61.2B | $402.1B |
| Net Income | $4.2B | $1.8B |
| Net Margin | 6.9% | 0.4% |
| ROE | N/A | 2.4% |
| ROA | 3.2% | 0.7% |
| Current Ratio | 0.67x | 0.84x |
| Debt/Equity | N/A | 0.85x |
| EPS | $2.36 | $1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs CVS: Frequently Asked Questions
Is ABBV or CVS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. ABBV is rated HOLD (70% confidence) while CVS is rated HOLD (70% confidence). This is not investment advice.
How does ABBV compare to CVS fundamentally?
AbbVie Inc. has ROE of N/A vs CVS HEALTH Corp's 2.4%. Net margins are 6.9% vs 0.4% respectively.
Which stock pays higher dividends, ABBV or CVS?
ABBV has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or CVS for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while CVS has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs CVS, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.